Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors

Anticancer Research

Volumn 22, Issue 3, 2002, Pages 1497-1504

  Cohen, Leonard A ^a   Marks, Paul A ^a   Rifkind, Richard A ^a   Amin, Shantu ^a   Desai, Dhimant ^a   Pittman, Brian ^a   Richon, Victoria M ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

Histone deacetylase (HDAC) inhibitor; Mammary tumor; Suberoylanilide hydroxamic acid (SAHA)

Indexed keywords

HISTONE DEACETYLASE INHIBITOR; METHYLNITROSOUREA; VORINOSTAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; TUMOR GROWTH;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; CARCINOGENS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; ENZYME INHIBITORS; FEMALE; GROWTH INHIBITORS; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036323115     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Histone deacetylase inhibitors: Inducers of differentiation and apoptosis of transformed cells
2. Differentiation: A suitable strategy for cancer chemotherapy
3. All trans-retinoic acid as a differentiation therapy for acute promyelocytic leukemia
4. Cellular differentiation, cytidine analogs and DNA methylation
5. Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate
6. A study of the mechanism of selenite-induced hypomethylated DNA and differentiation of Friend erythroleukemia cells
7. Vitamin D and its relevance to cancer
8. Second generation hybrid polar compounds are potent inducers of transformed cell differentiation
9. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
10. Suberoylanilide hydroxamic acid as a potential therapeutic agent for human breast cancer treatment
11. Mechanisms of suberoylanilide hydroxamic acid inhibition of mammary cell growth
12. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells
13. Chemopreventive efficacy of suberanilohydroxamic acid (SAHA) a cytodifferentiating agent, against tobacco-specific nitrosamine 4-(methylnitros-amino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in female A/J mice
14. A class of hybrid polar inducers of transformed cell differentiation are potent inhibitors of histone deacetylases
15. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
16. Histone acetylation and transcriptional regulatory mechanisms
17. Control of histone modifications
18. Histone acetylation in chromatin structure and transcription
19. Historic acetyltransferase complexes and their link to transcription
20. Chemoprevention of carcinogen-induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (SAHA)
21. Direct mutagenesis of H-ras 1 oncogenes by N-nitrosomethylurea during initiation of mammary carcinogenesis in rats
22. Influence of dietary fat on the induction of mammary tumors by N-nitrosomethylurea: Associated hormone changes and differences between Sprague-Dawley and F 344 rats
23. The synthesis of N-hydroxy-H1-phenyloctanediamide and its inhibitory effect of proliferation of AXC prostate cancer cells
24. Pathology of tumours in laboratory animals. Tumors of the rat. Tumour of the mammary gland
25. Nonparametric estimation from incomplete observation